Data / Form D filings / Nanocan Therapeutics Corp
Nanocan Therapeutics Corp: Form D filings
Nanocan Therapeutics Corp, a biotechnology company in National Harbor, MD, filed 2 Form D notices with the SEC between 2020 and 2025. The latest, on February 18, 2025, reports $5.1 million sold of a $6.5 million offering to 41 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 137 NATIONAL PLZ STE 300, National Harbor, MD, 20745
- Phone
- (202) 258-1591
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1820532
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | New notice | $6,457,220 | $5,059,984 | $1,397,236 | 41 | Dec 30, 2022 | sec.gov |
| Aug 27, 2020 | New notice | $1,400,000 | $1,125,000 | $275,000 | 6 | Jul 15, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dave P. Krasne | Executive Officer | |
| Eric C. Broyles | Executive Officer, Director | |
| Jacques P. Walker | Executive Officer, Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Feb 17, 2025 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Nanocan Therapeutics Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.